- Home
- KYMR vs ESBA Comparison
KYMR vs ESBA Comparison
Compare KYMR & ESBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- ESBA
- Stock Information
- Founded
- KYMR 2015
- ESBA N/A
- Country
- KYMR United States
- ESBA United States
- Employees
- KYMR N/A
- ESBA N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- ESBA
- Sector
- KYMR Health Care
- ESBA
- Exchange
- KYMR Nasdaq
- ESBA NYSE
- Market Cap
- KYMR 3.0B
- ESBA 3.1B
- IPO Year
- KYMR 2020
- ESBA 2013
- Fundamental
- Price
- KYMR $41.96
- ESBA $10.31
- Analyst Decision
- KYMR Buy
- ESBA
- Analyst Count
- KYMR 13
- ESBA 0
- Target Price
- KYMR $51.15
- ESBA N/A
- AVG Volume (30 Days)
- KYMR 415.6K
- ESBA 2.6K
- Earning Date
- KYMR 10-31-2024
- ESBA 01-01-0001
- Dividend Yield
- KYMR N/A
- ESBA 1.36%
- EPS Growth
- KYMR N/A
- ESBA N/A
- EPS
- KYMR N/A
- ESBA 0.27
- Revenue
- KYMR $87,563,000.00
- ESBA $758,432,000.00
- Revenue This Year
- KYMR N/A
- ESBA N/A
- Revenue Next Year
- KYMR $21.47
- ESBA N/A
- P/E Ratio
- KYMR N/A
- ESBA $38.15
- Revenue Growth
- KYMR 86.92
- ESBA 1.59
- 52 Week Low
- KYMR $17.89
- ESBA $7.85
- 52 Week High
- KYMR $53.27
- ESBA $11.50
- Technical
- Relative Strength Index (RSI)
- KYMR 34.56
- ESBA 44.14
- Support Level
- KYMR $45.16
- ESBA $10.30
- Resistance Level
- KYMR $53.23
- ESBA $10.99
- Average True Range (ATR)
- KYMR 2.58
- ESBA 0.20
- MACD
- KYMR -0.54
- ESBA -0.04
- Stochastic Oscillator
- KYMR 1.66
- ESBA 1.45
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymera's Pegasus targeted protein degradation platform harnesses the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients.
About ESBA EMPIRE STATE REALTY OP LIM PARTNER
Empire State Realty OP LP is the operating partner of Empire State Realty Inc. The company along with its partner manages, operates, acquires and repositions properties in Manhattan and the greater New York metropolitan area. The firm operates in two segments, Real Estate and Observatory. Through the Real Estate segment, it offers services related to the ownership, management, operation, acquisition, repositioning and disposition of its real estate assets. Under the Observatory segment, it operates the two observatories of the Empire State Building. The company generates maximum revenue from the Real Estate segment.